Patient's compliance is a contributor to failure of extended antithrombotic prophylaxis in colorectal surgery: prospective cohort study
- PMID: 33495879
- DOI: 10.1007/s00464-020-08271-3
Patient's compliance is a contributor to failure of extended antithrombotic prophylaxis in colorectal surgery: prospective cohort study
Abstract
Background: Venous thromboembolic events (VTE) continue to be a major source of morbidity following colorectal surgery. Selective extended VTE prophylaxis for high-risk patients is recommended; however, provider compliance is low. The purpose of this study is to evaluate whether the "global" extended use of enoxaparin in all colorectal patients is feasible and safe.
Methods: This is a prospective study conducted at a tertiary care center. All Patients undergoing elective colorectal procedures from November 1, 2017 to October 31, 2018 were discharged on 30 days of enoxaparin. Safety of use and patient compliance were examined.
Results: Total of 270 patients received extended prophylaxis during the study period (100% of intended patients) with five VTE recorded (1.85%). There was no significant difference in rates of VTE or complications when compared to years of selective prophylaxis (1.26% for 2016, 2.32% for 2017). Only 64% of patients reported full compliance.
Conclusion: Global use of extended enoxaparin prophylaxis is safe, but does not decrease rates of VTE when compared to selective use. Patient's non-adherence is likely a significant contributing factor.
Keywords: Colorectal surgery; Patient’s compliance; VTE prophylaxis.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.
References
-
- Novo-Veleiro I, Alvela-Suarez L, Costa-Grille A, Suarez-Dono J, Ferron-Vidan F, Pose-Reino A (2018) Compliance with current VTE prophylaxis guidelines and risk factors linked to complications of VTE prophylaxis in medical inpatients: a prospective cohort study in a Spanish internal medicine department. BMJ Open 8(5):e021288 - DOI
-
- Aloia TA, Geerts WH, Clary BM, Day RW, Hemming AW, D’Albuquerque LC et al (2016) Venous thromboembolism prophylaxis in liver surgery. J Gastrointest Surg 20(1):221–229 - DOI
-
- Horsted F, West J, Grainge MJ (2012) Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med 9(7):e1001275 - DOI
-
- Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E et al (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243(1):89–95 - DOI
-
- Kourlaba G, Relakis J, Mylonas C, Kapaki V, Kontodimas S, Holm MV et al (2015) The humanistic and economic burden of venous thromboembolism in cancer patients: a systematic review. Blood Coagul Fibrinolysis 26(1):13–31 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources